WE SHOW YOU THE PATH TO PROFIT

The Greatest Reward Lies Ahead

Webinar: Learn How Life Sciences Companies Benefit From The R&D Tax Credit And Orphan Drug Credit - Save my seat

Creating a plan to identify potential tax savings is complicated and confusing, but it doesn't have to be. At CTI, we have one simple goal: to show you a detailed path to maximum tax savings. With personalized service and state-of-the-art technology, you won't leave money on the table. We find you additional tax credits and incentives, without impacting your daily operations.

Diagnostics Discovery

Through our deep-dive diagnostic evaluation of your current operations and tax burden, we find every opportunity to maximize your tax savings.

Putting Location-Based Tax Incentive Programs To Work For Your BusinessDownload  Your Guide Today

Goal Charting

The next step toward financial growth is your Expectations Huddle, where you'll meet your expert support team and set goals and milestones for your savings journey.

Find Out If Your Business Qualifies For R&D Tax Credits Take The Quiz And Get  Your Results

Savings Destination Roadmap

We create a customized roadmap that outlines your path to success, with timelines and automated alerts updating you on the deliverables and milestones of all of your tax savings projects.

Latest Blog Posts

The #1 Best Practice For Capturing R&D Tax Credits

As your pharmaceutical company increases its research and development (R&D) activities to design and develop new or improved drugs, it’s critical to have a formal process in place to track your...Read more

The Orphan Drug Credit: 3 Key Considerations For Computing Qualifying Wages

As more and more pharmaceutical companies invest in new and improved drug development activities, certain drug indications dictate whether or not the medicine will be viable for a small or large...Read more

3 Key Ways To Drive Your Life Sciences Research With R&D Tax Credits

Many companies in the U.S. work in the life sciences industry, including firms working in the fields of pharmaceuticals, biomedical, biotechnology and medical devices. For the bulk of companies in...Read more